Rebuilding the foundation of health care under MACRA

whitePaper | May 15, 2022

The zero trust security framework is predicated on the foundational concept that implicit trust of users and devices in the environment increases the risk of a potential compromise. By eliminating this implicit trust and requiring strict identification and authentication throughout the network

whitePaper | March 3, 2023

Hospitals throughout the United States and worldwide have struggled with understaffing for years, with the effects of the COVID-19 pandemic pushing them to their limits.

whitePaper | May 14, 2022

Medical science is currently being transformed by scientific discoveries that will dramatically advance the way we diagnose and treat different diseases.

whitePaper | May 20, 2022

We, the G7 Health Ministers, met in Berlin, Germany, on 19 and 20 May 2022, at an extraordinary time of multiple, acute crises.

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | December 7, 2022

The target market for conducting global clinical trials has changed significantly, moving beyond pharmaceutical early adopters to the mainstream marketplace.